Medicinal Plants and Atherosclerosis: A Review on Molecular Aspects.

Abstract:

:Atherosclerosis is an inflammatory vascular disease that is characterized by progressive accumulation of cholesterol in the arterial walls and it is a major cause of cardiovascular disease. Issues related to the side effects of synthetic drugs have in recent times, led to the misuse of drugs, a lack of patient consultations, and consequently, a disruption in meticulous disease control. Therefore, a new insight into medicinal plants has recently emerged and much research has been conducted on these herbs in an attempt to prepare novel naturally based drugs. The aim of this review article was to scrutinize the molecular mechanisms of medicinal plants possessing effectiveness against atherosclerosis. To conduct the review, electronic searches were performed to retrieve potentially relevant publications, indexed within internet databases and reference textbooks concerning the effects and underlying molecular mechanisms of plants or their constituents used to treat atherosclerosis. Overall, medicinal plants facilitate atherosclerosis treatment through a variety of mechanisms which include the regulation of expression of inflammatory factors, stimulation of peroxisome proliferator-activated receptors (PPARs), inhibition of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMG-CoA reductase), promotion of ATP-binding cassette transporter A1 (ABCA1) as well as ATP-binding cassette transporter G (ABCG), facilitation of adiponectin activity, reduction of sterol regulatory element-binding proteins (SREBPs) and antioxidant activity. An increased perception of these herbal mechanistic links is an important prelude to the design of novel plant based drugs.

journal_name

Curr Pharm Des

authors

Gholipour S,Sewell RDE,Lorigooini Z,Rafieian-Kopaei M

doi

10.2174/1381612824666180911121525

subject

Has Abstract

pub_date

2018-01-01 00:00:00

pages

3123-3131

issue

26

eissn

1381-6128

issn

1873-4286

pii

CPD-EPUB-92958

journal_volume

24

pub_type

杂志文章,评审
  • Disruption of Circadian Rhythms and Sleep on Critical Illness and the Impact on Cardiovascular Events.

    abstract::The cardiovascular system exhibits significant daily rhythms in physiologic processes (heart rate, blood pressure, cardiac contractility and function), and molecular gene and protein expression. An increasing number of clinical and experimental studies demonstrate the circadian system is an important underlying mechan...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150706105926

    authors: Reitz CJ,Martino TA

    更新日期:2015-01-01 00:00:00

  • Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer's disease.

    abstract::Alzheimer's disease (AD) is a heterogeneous and progressive neurodegenerative disease which in Western society mainly accounts for clinical dementia. Inflammation plays a key role in AD and dissecting the genetics of inflammation may provide an answer to the possible treatment. Hence, the better understanding of diffe...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/138161208786264089

    authors: Balistreri CR,Grimaldi MP,Chiappelli M,Licastro F,Castiglia L,Listì F,Vasto S,Lio D,Caruso C,Candore G

    更新日期:2008-01-01 00:00:00

  • DNA-photocleavage agents.

    abstract::This review describes recent advances in the development of DNA-photocleavage agents. Major mechanisms of photosensitized DNA photocleavage are presented and the most popular categories of compounds are considered, which include metal complexes and many organic functional derivatives. DNA-targeted conjugates of photos...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612013397140

    authors: Da Ros T,Spalluto G,Boutorine AS,Bensasson RV,Prato M

    更新日期:2001-11-01 00:00:00

  • NAP (davunetide) provides functional and structural neuroprotection.

    abstract::NAP (davunetide) is an eight amino acid peptide (NAPVSIPQ) that has been shown to provide potent neuroprotection, in vitro and in vivo. In human clinical trials, NAP has been shown to increase memory scores in patients suffering from amnestic mild cognitive impairment, a precursor to Alzheimer's disease and to enhance...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211795589373

    authors: Gozes I

    更新日期:2011-01-01 00:00:00

  • Epidemiology of Non-alcoholic Fatty Liver Disease in North America.

    abstract::Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming the most common cause of chronic liver disease worldwide. This is primarily driven by the global epidemic of obesity and diabetes as well as the aging of the general population. Most of the epidemiology data of NAFLD for North America are published from stud...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612826666200303114934

    authors: Arshad T,Golabi P,Henry L,Younossi ZM

    更新日期:2020-01-01 00:00:00

  • Molecular mapping in the CNS.

    abstract::Since ancient times the operation of the brain has elicited more than usual interest. Data mining of the human genome is revealing that many CNS abnormalities have a genetic component. As yet this information can not be used directly to cure or ameliorate specific CNS disorders although this is regarded as having grea...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612023394250

    authors: Wong MG,Tehan BG,Lloyd EJ

    更新日期:2002-01-01 00:00:00

  • Lipid-based Nanocarriers for Cancer and Tumor Treatment.

    abstract::Cancer and tumor have been major reasons for numerous deaths in this century across the world. Many strategies have been designed to treat, diagnose, or prevent cancer. The success of chemotherapy largely depends on drug targeting. The advent of nanotechnology has vastly improved drug delivery for targeting and diagno...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200720235752

    authors: Ansari MT,Ramlan TA,Jamaluddin NN,Zamri N,Salfi R,Khan A,Sami F,Majeed S,Hasnain MS

    更新日期:2020-01-01 00:00:00

  • Vitamins in Heart Failure: Friend or Enemy?

    abstract:BACKGROUND:The failing heart is characterized by a depleted metabolic energy reserve and the upregulation of several molecular mechanisms leading to cardiac hypertrophy, inflammation, fibrosis, angiogenesis, and apoptosis. Dietary or non-dietary supplementation of vitamins could potentially benefit energy balance. OBJ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666170321094711

    authors: Georgiopoulos G,Chrysohoou C,Vogiatzi G,Magkas N,Bournelis I,Bampali S,Gruson D,Tousoulis D

    更新日期:2017-01-01 00:00:00

  • Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activities.

    abstract::About 50 peptides, and a similar number of peptide receptors, are known to be present in the gut and this amount is likely to rise significantly over the next few years. While there has been a massive research effort to define their functions and their anatomical distribution in the central nervous system (CNS), the u...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208783330745

    authors: Motilva V,Talero E,Calvo JR,Villegas I,Alarcón-de-la-Lastra C,Sánchez-Fidalgo S

    更新日期:2008-01-01 00:00:00

  • The impact of diabetes mellitus on coronary artery disease: new therapeutic approaches.

    abstract::Patients with diabetes mellitus (DM) type 2 have a high prevalence of coronary artery disease (CAD), as diabetes is implicated in the formation of atherosclerotic plaque. Hyperglycemia, elevated free fatty acid, increased amount of circulating end-glucosylated serum products and insulin resistance are the main mechani...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161209788453185

    authors: Tousoulis D,Kampoli AM,Papageorgiou N,Papaoikonomou S,Antoniades C,Stefanadis C

    更新日期:2009-01-01 00:00:00

  • Cellular immunity and acute hepatitis C infection.

    abstract::Hepatitis C virus (HCV) infects an estimated 170 million people globally and persistent infection within the liver is the usual outcome of infection. The resulting liver disease leads to substantial morbidity and to date no vaccine exists. Furthermore the treatments available are frequently ineffective. A minority of ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208784746806

    authors: Fitzmaurice K,Klenerman P

    更新日期:2008-01-01 00:00:00

  • Insulin resistance, oxidative stress and cardiovascular complications: role of sirtuins.

    abstract::Cardiovascular disease (CVD) is one of the major lifestyle associated disorders and leading causes of death worldwide. The incidence of CVD in diabetic patients has increased up to 3 folds and it became the major risk for diabetes associated morbidity and mortality. Insulin resistance and oxidative stress both play a ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990372

    authors: Bagul PK,Banerjee SK

    更新日期:2013-01-01 00:00:00

  • Opiate-induced analgesia: contributions from mu, delta and kappa opioid receptors mouse mutants.

    abstract::The three opioid receptors, mu, delta and kappa all mediate analgesia, and knockout mice with opioid receptor deletion have proven unique tools to investigate in vivo opioid pharmacology. Since a few years, a number of new mouse lines have been engineered, with several distinct mutations of the mu receptor, to assess ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/138161281942140105163727

    authors: Gavériaux-Ruff C

    更新日期:2013-01-01 00:00:00

  • Runx2/Cbfa1: a multifunctional regulator of bone formation.

    abstract::Runx2/Cbfa/AML3 is a member of the runt homology domain family of transcription factors, essential for osteoblast differentiation and bone formation. Defining the molecular mechanisms by which Runx2 can function as a master regulatory gene for activating the program of osteoblastogenesis has provided novel insights fo...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612033453659

    authors: Lian JB,Stein GS

    更新日期:2003-01-01 00:00:00

  • Barriers to Risk Stratification Accuracy in Ischemic Heart Disease in Women: The Role of Non-Obstructive Coronary Artery Disease.

    abstract:BACKGROUND:A substantial part of literature has been centered on sex differences in the clinical aspects of ischemic heart disease (IHD). Many reports have documented differences in the presentation and risk profile between women and men. Such differences drive sex-related inequalities in the referral and treatment of ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160311115344

    authors: Cenko E,Bugiardini R

    更新日期:2016-01-01 00:00:00

  • The dualistic nature of immune modulation in Alzheimer's disease: lessons from the transgenic models.

    abstract::There is extensive evidence that changes in immune system activation accompany the pathological changes of Alzheimer's disease (AD), but a mechanistic understanding of how the immune system actually participates in disease pathogenesis is still largely lacking. Because of the complexity of the immunological response, ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161205774370843

    authors: Nelson RB

    更新日期:2005-01-01 00:00:00

  • Anesthetic cardioprotection in clinical practice from proof-of-concept to clinical applications.

    abstract::In 2007, the American Heart Association (AHA) recommended (class IIa, level of evidence B) in their guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery volatile anesthetics as first choice for general anesthesia in hemodynamically stable patients at risk for myocardial ischemia. This ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612820666140204120829

    authors: Zaugg M,Lucchinetti E,Behmanesh S,Clanachan AS

    更新日期:2014-01-01 00:00:00

  • In silico screening for potent inhibitors against the NS3/4A protease of hepatitis C virus.

    abstract::Hepatitis C virus (HCV) infections are a serious viral health problem globally, causing liver cirrhosis and inflammation that can develop to hepatocellular carcinoma and death. Since the HCV NS3/4A protease complex cleaves the scissile peptide bond in the viral encoded polypeptide to release the non-structural protein...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/13816128113199990632

    authors: Meeprasert A,Rungrotmongkol T,Li MS,Hannongbua S

    更新日期:2014-01-01 00:00:00

  • Modulation of the intrinsic properties of motoneurons by serotonin.

    abstract::Serotonin (5-HT) is one of the main transmitters in the nervous system. Serotonergic neurons in the raphe nuclei in the brainstem innervate most parts of the central nervous system including motoneurons in the spinal cord and brainstem. This review will focus on the modulatory role that 5-HT exerts on motoneurons and ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990341

    authors: Perrier JF,Rasmussen HB,Christensen RK,Petersen AV

    更新日期:2013-01-01 00:00:00

  • Heme oxygenase-1 as a therapeutic target in neurodegenerative diseases and brain infections.

    abstract::Heme oxygenase-1 (HO-1) catalyzes the degradation of heme to generate carbon monoxide, biliverdin and free iron. Increased HO-1 levels constitute an anatomopathological feature of many neurological diseases, such as neurodegenerative disorders and brain infections, which correlate with exacerbated oxidative stress and...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208783597407

    authors: Cuadrado A,Rojo AI

    更新日期:2008-01-01 00:00:00

  • Nanoparticle-Based Combination Therapy for Cancer Treatment.

    abstract::In recent years, combination of different types of therapies using nanoparticles has emerged as an advanced strategy for cancer treatment. Most of all, combination of chemotherapeutic drug and siRNA in nanoformulation has shown a great potential, because siRNA-mediated specific gene silencing can compensate for the in...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150531165059

    authors: Yhee JY,Son S,Lee H,Kim K

    更新日期:2015-01-01 00:00:00

  • Systemic sclerosis-related pulmonary hypertension: unique characteristics and future treatment targets.

    abstract::Pulmonary arterial hypertension (PAH) is a severe vascular complication of connective tissue diseases. In the context of systemic sclerosis (SSc), PAH is a devastating disease with a dramatic impact on prognosis and survival. Despite advances in early diagnosis and the development of new targeted treatments, SSc-relat...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212799504704

    authors: Dimitroulas T,Giannakoulas G,Karvounis H,Settas L,Kitas GD

    更新日期:2012-01-01 00:00:00

  • Is there a Relationship Between Vitamin D and Endometriosis? An Overview of the Literature.

    abstract:BACKGROUND:Vitamin D is involved in the physiological functions of several tissues, however, its deficiency may contribute to the development of various disorders. Recent research has been focusing on the role of vitamin D in the pathogenesis of endometriosis based on the evidence of the presence of vitamin D receptor ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666190722095401

    authors: Giampaolino P,Della Corte L,Foreste V,Bifulco G

    更新日期:2019-01-01 00:00:00

  • Research Advances in Molecular Modeling in Cyclodextrins.

    abstract:BACKGROUND:Cyclodextrins (CDs), as one type of the novel pharmaceutical excipients, have been widely used in drug delivery and pharmaceutical industry. Over the past decades, a large amount of molecular modeling studies in CDs were reported for profound understanding of structural, dynamic and energetic features of CDs...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666161208142617

    authors: Zhao Q,Zhang W,Wang R,Wang Y,Ouyang D

    更新日期:2017-01-01 00:00:00

  • Ghrelin as a potential anti-obesity target.

    abstract::In order to develop an effective pharmacological treatment for obesity, an endogenous factor that promotes a positive energy balance by increasing appetite and decreasing fat oxidation could represent the drug target scientists have been looking for. The recently discovered gastric endocrine agent ghrelin, which appea...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612033454748

    authors: Horvath TL,Castañeda T,Tang-Christensen M,Pagotto U,Tschöp MH

    更新日期:2003-01-01 00:00:00

  • Pharmacogenetics of non-small cell lung cancer (NSCLC): time to "work it out"?

    abstract::The disappointing results in long-term survival of patients affected by non-small cell lung cancer (NSCLC) may be attributed, at least in part, to the lack of knowledge on the way by which genetic characteristics in normal and neoplastic cells affect responsiveness as well as metabolism of chemotherapy and new targete...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113196660756

    authors: Galvani E,Toffalorio F,Peters GJ,De Pas T,Giovannetti E

    更新日期:2014-01-01 00:00:00

  • Therapeutic effects of micronutrient supplements on sperm parameters: Fact or Fiction?

    abstract:BACKGROUND:Despite the limited evidence about the effect of micronutrient supplementation on the semen quality, many micronutrient supplements have been used to improve male fertility. Approximately, 40%-50% of male infertility cases in general and up to 80% in men with idiopathic infertility cases are caused by oxidat...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200415173537

    authors: Dimitriadis F,Tsounapi P,Zachariou A,Kaltsas A,Sokolakis I,Hatzichristodoulou G,Symeonidis EN,Kotsiris D,Gabales MR,Vlachopoulou E,Takenaka A,Sofikitis N

    更新日期:2020-04-15 00:00:00

  • Antibiotic-resistant H. pylori infection and its treatment.

    abstract::Helicobacter pylori infection causes progressive damage to gastric mucosa and results in serious disease such as peptic ulcer disease, MALT lymphoma, or gastric adenocarcinoma in 20% to 30% of patients. The current approach is to make a firm diagnosis, give combination antibiotic and antisecretory therapy, and confirm...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612003399077

    authors: Graham DY,Qureshi WA

    更新日期:2000-10-01 00:00:00

  • Cognition and Emotions in Recurrent Depressive Disorders - The Role of Inflammation and the Kynurenine Pathway.

    abstract::Separating emotions from cognition seems impossible in everyday experiences of a human being. Emotional processes have an impact on the ability of planning and solving problems, or decision-making skills. They are a valuable source of information about ourselves, our partners in interactions and the surrounding world....

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666151230110738

    authors: Talarowska M,Galecki P

    更新日期:2016-01-01 00:00:00

  • The Lord of the Bacteria: The Fellowship of the Leader and Other Serine Protease Inhibitors.

    abstract::Since antibiotics use is currently limited due to undesired side effects and the increasing antibiotic resistance of various bacteria strains, there is a pressing need to develop new strategies and methods preventing epidemic outbreaks. The virulent potency of bacteria relies on a number of different extracellularly s...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666181219163922

    authors: Burchacka E,Sieńczyk M

    更新日期:2018-01-01 00:00:00